Buy Dolutegravir/Lamivudine + Tenofovir Disoproxil – FDA Certified Manufacturer
$85.00 USD
Acriptega™ is a licensed generic of Dovato® + Viread® produced by Mylan Pharmaceuticals®, a US FDA certified manufacturer, in India. It’s a fixed-dose combination recommended by the WHO as a first-line complete regimen for treating HIV/AIDS.
Bottle Size: 30 Tablets
Active Ingredients : Dolutegravir 50 mg / Lamivudine 300 mg + Tenofovir Disoproxil Fumarate 300 mg
Produced by Mylan Pharmaceuticals®
No prescription? You can order our prescription service at checkout (cost is $10 USD)
Delivery of this medication is fully guaranteed and takes 4 to 6 days by Express Mail
In stock
- Acriptega™ is a fixed dose combination WHO recommended first-line antiretroviral (ARV) complete regimen treatment option for people living with HIV/AIDS. The recommendation is based on Dolutegravir’s improved tolerability, higher antiretroviral efficacy, lower rates of treatment discontinuation, a higher genetic barrier to resistance and fewer drug interactions than other ARV drugs. Additionally, both the U.S. Department of Health and Human Services and the European AIDS Clinical Society include Dolutegravir as a preferred medicine on their HIV/AIDS treatment guidelines.
Only logged in customers who have purchased this product may leave a review.
Related products
$82.00 USD – $243.00 USD
This product has multiple variants. The options may be chosen on the product page
$198.00 USD
Reviews
There are no reviews yet.